Results 11 to 20 of about 12,524 (227)

ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis

open access: greenPharmacological Research, 2023
Oxidative disruption of dopaminergic neurons is regarded as a crucial pathogenesis in Parkinson's disease (PD), eventually causing neurodegenerative progression.
Kun Li   +12 more
doaj   +5 more sources

JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer [PDF]

open access: yesCell Death and Disease
Chemotherapy remains the cornerstone of gastric cancer (GC) treatment, with Oxaliplatin (OXA) being a critical first-line agent. However, chemotherapy resistance, compounded by increased stemness, poses a significant challenge in GC management.
Gege Shu   +10 more
doaj   +5 more sources

ALOX5 promoter genotype and response to montelukast in moderate persistent asthma [PDF]

open access: bronzeRespiratory Medicine, 2008
It was hypothesized that asthmatic patients with mutant alleles in the leukotriene pathway should not respond to leukotriene receptor antagonists and the concept of a tailored treatment is increasingly supported.Sixty-one patients (mean age 24.9 years, range 14-52) with moderate persistent asthma were clinical and immunological assess prior and after a
J J Telleria   +2 more
exaly   +6 more sources

Tuft cell cysteinyl leukotrienes are necessary for rhinovirus-induced mucus metaplasia, type 2 inflammation and airway hyperresponsiveness in immature mice [PDF]

open access: yesFrontiers in Immunology
IntroductionEarly-life wheezing-associated respiratory tract infections with rhinovirus (RV) are considered risk factors for asthma development. Cysteinyl leukotrienes (cysLTs) are pro-inflammatory lipid mediators synthesized from arachidonic acid by 5 ...
De’Jana T. Parker   +11 more
doaj   +2 more sources

Multiomics integrated analysis and experimental validation identify TLR4 and ALOX5 as oxidative stress-related biomarkers in intracranial aneurysms [PDF]

open access: goldJournal of Neuroinflammation
Background Intracranial aneurysm (IA) is a severe cerebrovascular disease, and effective gene therapy and drug interventions for its treatment are still lacking.
Lvyin Luo   +13 more
doaj   +2 more sources

Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression [PDF]

open access: goldCancer Biology & Medicine
Objective: Neutrophils are one of the most predominant infiltrating leukocytes in lung cancer tissues and are associated with lung cancer progression. How neutrophils promote lung cancer progression, however, has not been established.
Lulu Han   +8 more
doaj   +2 more sources

MLL-AF4 upregulates 5-lipoxygenase expression in t(4;11) leukemia cells via the ALOX5 core promoter [PDF]

open access: goldFrontiers in Pharmacology
5-Lipoxygenase (5-LO), encoded by the gene ALOX5, is implicated in several pathologies. As key enzyme in leukotriene biosynthesis, 5-LO plays a central role in inflammatory diseases, but the 5-LO pathway has also been linked to development of certain ...
Marius Hyprath   +4 more
doaj   +2 more sources

Shenqi Dihuang Decoction Attenuates ALOX5-Mediated Ferroptosis in Diabetic Nephropathy via AMPK/mTOR and TGF-β/Smads Pathways [PDF]

open access: yesJournal of Diabetes Research
To explore the underlying mechanisms about that Shenqi Dihuang decoction (SDD) attenuated diabetic nephropathy (DN), mice were fed on high-sugar and high-fat diet and treated with streptozotocin (STZ) to induce DN model, as well as HK-2 cells treated ...
Li Zhao   +4 more
doaj   +2 more sources

Irisin regulates lipid metabolism and ferroptosis in ovarian cancer cells by modulating the ALOX5-5-HETE-PD-L1 axis [PDF]

open access: yesScientific Reports
This study investigates the role of arachidonate 5-lipoxygenase (ALOX5) in upregulating programmed death-ligand 1 (PD-L1) expression via its metabolite 5-hydroxyeicosatetraenoic acid (5-HETE) in ovarian cancer cells, and explores the effects on lipid ...
Huichun Cai, Caiyun Huang, Zhenwei Zhang
doaj   +2 more sources

Home - About - Disclaimer - Privacy